STDs Biomarker
Collection Type: Blood
Related System: STDs
Chlamydia IgM is a blood test that detects IgM-class antibodies directed against Chlamydia trachomatis. IgM antibodies typically arise early after exposure and so their presence suggests recent or acute infection rather than remote or past exposure (which is better indicated by IgG). This test is sometimes used when a direct detection test (NAAT) cannot be performed, in neonates with conjunctivitis or pneumonia, or in systemic complications (e.g., reactive arthritis). Symptoms prompting testing include urethral or vaginal discharge, dysuria, pelvic or lower abdominal pain, rectal pain or bleeding, conjunctivitis in infants, and neonatal respiratory symptoms. Positivity rates and interpretation vary by age, sex, timing after exposure, pregnancy status, and prior antibiotic treatment.
Run our symptom checker to see if this test is right for you
Symptom CheckerIndex <0.9 (negative)
Q: What does chlamydia IgM mean?
A: Chlamydia IgM refers to early immunoglobulin M antibodies produced after Chlamydia exposure. A positive IgM suggests recent or acute infection, but IgM tests can cross-react or give false positives and aren’t the diagnostic gold standard. Diagnosis is confirmed by nucleic acid amplification testing (NAAT). Clinical correlation, retesting, and partner testing/treatment are recommended if acute infection is suspected.
Q: What is the IgM result for chlamydia?
A: IgM antibodies to Chlamydia trachomatis, when positive, may suggest a recent or primary infection, but IgM testing is neither highly sensitive nor specific for chlamydia. IgM can be absent in reinfections and give false positives; a negative IgM does not rule out current infection. Nucleic acid amplification tests (NAATs) on urine or swabs are the preferred, reliable diagnostic method.
Q: What is the difference between chlamydia IgM and IgG?
A: Chlamydia IgM indicates a recent or acute immune response, appearing early after infection but can be transient and less specific. IgG appears later, persists for months to years, and usually reflects past or longstanding exposure. Serologic IgM/IgG testing has limitations (sensitivity, cross‑reactivity) and is not the preferred method for diagnosing current urogenital chlamydia; NAATs are recommended.
Q: What does it mean when chlamydia IgM is positive?
A: A positive Chlamydia IgM indicates the immune system has recently produced antibodies, suggesting a recent or active infection. IgM results alone aren’t definitive—false positives, cross‑reactivity or persistent antibodies can occur. Confirm with a nucleic acid amplification test (NAAT) and clinical assessment. If infection is confirmed, prompt treatment and partner notification/testing are recommended.
Q: What if IgM is positive?
A: If IgM is positive it usually indicates a recent or active infection because IgM is the first antibody produced. Interpretation depends on symptoms, timing and test specificity—false positives or cross‑reactions can occur. Your clinician may order confirmatory tests (PCR or repeat serology for IgG seroconversion), start appropriate treatment or precautions, and advise follow‑up testing to clarify status.
Q: What if chlamydia is positive?
A: If a chlamydia test is positive, see a healthcare provider promptly for recommended antibiotics (often doxycycline or azithromycin). Treat all recent sexual partners and avoid sex until seven days after single-dose treatment or until finishing multi-day therapy and partners are treated. Get retested about three months and screened for other STIs. Untreated chlamydia can cause pelvic inflammatory disease, infertility, or pregnancy complications.